Soonmyung Paik

机构：Yonsei University, Theragen, Yonsei University Health System · ORCID：0000-0001-9688-6480

发表论文 339 篇 · 总被引 65098 次 · h-index 75

代表论文

• Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer (2023 · Journal of Clinical Oncology · 被引 160)
• Extending the duration of endocrine treatment for early breast cancer: patient-level meta-analysis of 12 randomised trials of aromatase inhibitors in 22 031 postmenopausal women already treated with at least 5 years of endocrine therapy (2025 · The Lancet · 被引 38)
• Unique structural configuration of EV-DNA primes Kupffer cell-mediated antitumor immunity to prevent metastatic progression (2024 · Nature Cancer · 被引 36)
• Machine Learning Predicts Oxaliplatin Benefit in Early Colon Cancer (2024 · Journal of Clinical Oncology · 被引 22)
• Copy number aberrations in circulating tumor DNA enables prognosis prediction and molecular characterization of breast cancer (2023 · JNCI Journal of the National Cancer Institute · 被引 19)
• Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor–Positive, Early-Stage Breast Cancer (2024 · Journal of Clinical Oncology · 被引 17)